Skip to content

Clinical trials

Phase 4 Multiple Sclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 4 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20132
20142
20171
20182
20191
20212
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen3
Bayer2
Merck KGaA, Darmstadt, Germany2
Novartis Pharmaceuticals2
Astellas Pharma Inc1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1
Oxford University Hospitals NHS Trust1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis15
Multiple Sclerosis, Relapsing-Remitting2
Brain Injuries1
Flushing1
Muscle Spasticity1
Pain1
Spinal Cord Diseases1
Spinal Cord Injuries1
Stroke1
Urinary Bladder, Neurogenic1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.